Clinical trial
CARE-AF: Cardiac Assessment for Recurrent Stroke Risk Evaluation in Atrial Fibrillation
NCT06954610 is registered in ClinicalTrials.gov with Insel Gruppe AG, University Hospital Bern as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- CARE-AF: Cardiac Assessment for Recurrent Stroke Risk Evaluation in Atrial Fibrillation
- Lead sponsor
- Insel Gruppe AG, University Hospital Bern
- Phase
- Observational
- Overall status
- Recruiting
- Start date
- November 4, 2025
- Completion date
- June 30, 2028
- Enrollment
- 500 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
arrhythmias, cardiac, atrial fibrillation, brain diseases, brain infarction, brain ischemia, cardioembolic stroke, central nervous system diseases, cerebrovascular disorders, heart diseases, infarction cerebral, ischemia, ischemic stroke, stroke, vascular diseases